Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health Canada Seeks Alcohol Interaction Data For Slow-Release Opioids

This article was originally published in The Pink Sheet Daily

Executive Summary

Manufacturers have six months to submit data on potential dose dumping due to interaction with alcohol.

You may also be interested in...



Purdue Signs On To Market Labopharm's Once-Daily Tramadol

Labopharm will receive up to $170 mil. under the licensing deal, including $20 mil. up front and $40 mil. upon NDA approval.

Purdue Signs On To Market Labopharm's Once-Daily Tramadol

Labopharm will receive up to $170 mil. under the licensing deal, including $20 mil. up front and $40 mil. upon NDA approval.

FDA Requests Strengthened Warnings For Extended-Release Morphine Avinza

The labeling change request coincides with the withdrawal of Purdue's extended-release hydromorphone product Palladone due to the potential for serious alcohol-related adverse events. Ligand will intensify warnings about alcohol use with Avinza while further information on the risk is gathered.

Topics

UsernamePublicRestriction

Register

LL1135495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel